Literature DB >> 28137762

Pregnancy outcomes in women with rheumatoid arthritis ever treated with rituximab.

Diederik De Cock1, Lucy Birmingham1, Kath D Watson1, Lianne Kearsley-Fleet1, Deborah P Symmons1,2, Kimme L Hyrich1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28137762     DOI： 10.1093/rheumatology/kew493

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  5 in total

Review 1.  A comprehensive review of rituximab therapy in rheumatoid arthritis patients.

Authors:  Soheil Tavakolpour; Samira Alesaeidi; Mohammad Darvishi; Mojtaba GhasemiAdl; Sahar Darabi-Monadi; Meisam Akhlaghdoust; Somayeh Elikaei Behjati; Arash Jafarieh
Journal:  Clin Rheumatol       Date:  2019-08-01       Impact factor: 2.980

2.  Pregnancy outcomes of a joint obstetric and rheumatology clinic in a tertiary centre: a 2-year retrospective study of 98 pregnancies.

Authors:  Ryan Malcolm Hum; Trixy David; Yen June Lau; Hajira Iftikhar; Sue Thornber; Louise Simcox; Ian Bruce; Clare Tower; Pauline Ho
Journal:  Rheumatol Adv Pract       Date:  2022-03-28

3.  Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD.

Authors:  Gitanjali Das; Vincent Damotte; Jeffrey M Gelfand; Carolyn Bevan; Bruce A C Cree; Lynn Do; Ari J Green; Stephen L Hauser; Riley Bove
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-03-19

4.  Pregnancy outcomes in women with pemphigus exposed to rituximab before or during pregnancy.

Authors:  Azin Dehghanimahmoudabadi; Nika Kianfar; Marwa Akhdar; Shayan Dasdar; Kamran Balighi; Hamidreza Mahmoudi; Maryam Daneshpazhooh
Journal:  Int J Womens Dermatol       Date:  2022-07-12

5.  Parental Distress and Affective Perception of Hospital Environment after a Pictorial Intervention in a Neonatal Intensive Care Unit.

Authors:  Erica Neri; Federica Genova; Marcello Stella; Alessandra Provera; Augusto Biasini; Francesca Agostini
Journal:  Int J Environ Res Public Health       Date:  2022-07-22       Impact factor: 4.614
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.